BSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/03/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization75,976 mln
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-1.8
Caution advised
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.03
Debt-free
ROE
-84.37
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Suven Life Sciences Limited is a clinical-stage biopharmaceutical company headquartered in Hyderabad, India, focused on developing new medicines for brain-related conditions such as Alzheimer's disease, depression, and sleep and cognitive disorders. The company has several drug candidates at various stages of development targeting the central nervous system, along with one candidate aimed at gastrointestinal conditions. Founded in 1989 and operating across India, the United States, Europe, and other markets, Suven Life Sciences functions as a subsidiary of Jasti Property and Equity Holdings Private Limited.
